COX-2 inhibitors: a potential target for drug therapy in the management of colorectal cancer.


Colorectal cancer is currently the third most common cancer in Malaysia. Elevated expression of COX-2, an induced cyclooxygenase isoenzyme, has been seen in colonic adenomas and colorectal carcinoma. There is evidence that inhibition of this COX-2 can decrease the risk of colorectal cancer. Selective COX-2 inhibitors may have a role in reducing the risk of… (More)


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.